Masimo Corp (Masimo) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring technologies, medical devices and sensors to improve patient care. The company’s proprietary technologies include signal extraction technology (SET) that helps detect life-threatening events; and rainbow SET platform. Its major products include patient monitors, pulse oximeters, central monitoring systems, specialty sensors, circuit boards, remote-alarms, and monitoring solutions. The company also markets products directly and through a network of distributors and original equipment manufacturers to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long term care facilities and consumers. The company operates in North and South America, Europe, the Middle East, Africa, Asia, and Australia. Masimo is headquartered in Irvine, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Masimo Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Masimo Corp Company Overview
- Masimo Corp Company Snapshot
- Masimo Corp Pipeline Products and Ongoing Clinical Trials Overview
- Masimo Corp - Pipeline Analysis Overview
- Business Description
- Masimo Corp - Key Facts
- Masimo Corp - Major Products and Services
- Masimo Corp Pipeline Products by Development Stage
- Masimo Corp Ongoing Clinical Trials by Trial Status
- Masimo Corp Pipeline Products Overview
- Eve
- Eve Product Overview
- iSpO2 Rx
- iSpO2 Rx Product Overview
- LiDCO IM System
- LiDCO IM System Product Overview
- LiDCOrapid
- LiDCOrapid Product Overview
- LiDCOrapid Clinical Trial
- Masimo Rainbow SET Pulse CO-Oximetry - RPVi
- Masimo Rainbow SET Pulse CO-Oximetry - RPVi Product Overview
- rainbow Super DCI-mini sensor - Continuous Measurement Version
- rainbow Super DCI-mini sensor - Continuous Measurement Version Product Overview
- Rainbow SuperSensor
- Rainbow SuperSensor Product Overview
- Root Iris Display Mobile App
- Root Iris Display Mobile App Product Overview
- Superset
- Superset Product Overview
- Masimo Corp - Key Competitors
- Masimo Corp - Key Employees
- Masimo Corp - Key Employee Biographies
- Masimo Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Masimo Corp, Recent Developments
- May 29, 2024: Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data
- May 20, 2024: Masimo Receives Sustainability Seal of Approval from Practice Greenhealth
- May 16, 2024: Masimo Receives Additional 510(k) Clearance For Stork Baby Monitoring System
- May 09, 2024: Regulatory Clearance for Leo Cancer Care’s Upright Technology for Radiation Therapy
- May 06, 2024: Masimo Receives FDA Clearance for Stork Over-the-Counter (OTC) Baby Monitoring System
- Feb 14, 2024: Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
- Feb 08, 2024: New Peer-Reviewed Study Finds That Masimo Set Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
- Jan 17, 2024: Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches
- Dec 26, 2023: Masimo Receives 510(k) Clearance for Stork Baby Monitoring System
- Dec 19, 2023: Masimo’s baby monitoring system receives US FDA clearance
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Masimo Corp Pipeline Products and Ongoing Clinical Trials Overview
- Masimo Corp Pipeline Products by Equipment Type
- Masimo Corp Pipeline Products by Indication
- Masimo Corp Ongoing Clinical Trials by Trial Status
- Masimo Corp, Key Facts
- Masimo Corp, Major Products and Services
- Masimo Corp Number of Pipeline Products by Development Stage
- Masimo Corp Pipeline Products Summary by Development Stage
- Masimo Corp Ongoing Clinical Trials by Trial Status
- Masimo Corp Ongoing Clinical Trials Summary
- Eve - Product Status
- Eve - Product Description
- iSpO2 Rx - Product Status
- iSpO2 Rx - Product Description
- LiDCO IM System - Product Status
- LiDCO IM System - Product Description
- LiDCOrapid - Product Status
- LiDCOrapid - Product Description
- LiDCOrapid - Accuracy of Mini-Fluid Challenge Test in Predicting Fluid Responsiveness in Patients Undergoing Pulmonary Lobectomy with One-Lung Ventilation
- Masimo Rainbow SET Pulse CO-Oximetry - RPVi - Product Status
- Masimo Rainbow SET Pulse CO-Oximetry - RPVi - Product Description
- rainbow Super DCI-mini sensor - Continuous Measurement Version - Product Status
- rainbow Super DCI-mini sensor - Continuous Measurement Version - Product Description
- Rainbow SuperSensor - Product Status
- Rainbow SuperSensor - Product Description
- Root Iris Display Mobile App - Product Status
- Root Iris Display Mobile App - Product Description
- Superset - Product Status
- Superset - Product Description
- Masimo Corp, Key Employees
- Masimo Corp, Key Employee Biographies
- Masimo Corp, Subsidiaries
- Glossary
- Masimo Corp Pipeline Products by Equipment Type
- Masimo Corp Pipeline Products by Development Stage
- Masimo Corp Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Shenzhen Mindray Bio-Medical Electronics Co Ltd
- Medtronic Plc
- Harman International Industries Inc
- Hologic Inc
- Edwards Lifesciences Corp
- Bang & Olufsen AS
